WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017204582) PHARMACEUTICAL COMPOSITION COMPRISING AN AMIDE DERIVATIVE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF INHIBITING GROWTH OF CANCER CELLS AND A STABILIZER HAVING LOW MELTING POINT
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/204582 International Application No.: PCT/KR2017/005480
Publication Date: 30.11.2017 International Filing Date: 25.05.2017
IPC:
A61K 31/519 (2006.01) ,A61K 31/496 (2006.01) ,A61K 47/10 (2017.01) ,A61K 47/38 (2006.01) ,C07D 495/04 (2006.01)
Applicants: HANMI PHARM. CO., LTD.[KR/KR]; 214, Muha-ro, Paltan-myeon Hwaseong-si Gyeonggi-do 18536, KR
Inventors: JUNG, Myeong Ki; KR
PARK, Caleb Hyungmin; KR
KIM, Jin Cheul; KR
KIM, Youg Il; KR
PARK, Jae Hyun; KR
WOO, Jong Soo; KR
Agent: Y.P.LEE, MOCK & PARTNERS; 12F Daelim Acrotel, 13 Eonju-ro 30-gil Gangnam-gu, Seoul 06292, KR
Priority Data:
10-2016-006597327.05.2016KR
Title (EN) PHARMACEUTICAL COMPOSITION COMPRISING AN AMIDE DERIVATIVE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF INHIBITING GROWTH OF CANCER CELLS AND A STABILIZER HAVING LOW MELTING POINT
(FR) COMPOSITION PHARMACEUTIQUE COMPRENANT UN DÉRIVÉ AMIDE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI INHIBANT LA CROISSANCE DE CELLULES CANCÉREUSES ET UN STABILISANT AYANT UN POINT DE FUSION BAS
Abstract: front page image
(EN) The present invention relates to a pharmaceutical composition comprising a thienopyrimidine compound, or a pharmaceutically acceptable salt thereof, or a hydrate of a pharmaceutically acceptable salt thereof and one or more low melting point stabilizer(s) inhibiting generation of impurities, and a pharmaceutical dosage form prepared using and comprising the same.
(FR) La présente invention concerne une composition pharmaceutique comprenant un composé de thiénopyrimidine, ou un sel pharmaceutiquement acceptable de celui-ci, ou un hydrate d'un sel pharmaceutiquement acceptable de celui-ci et un ou plusieurs stabilisant(s) à point de fusion bas inhibant la génération d'impuretés, et une forme pharmaceutique préparée au moyen de celle-ci et comprenant celle-ci.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)